Table 3.
Groups | Total Glutathione (μmol/L) | GSH (μmol/L) | GSSG (μmol/L) | GSH/GSSG Ratio | GPx Activity (U/g Hb) |
---|---|---|---|---|---|
C (n = 12) | 1304.56 ± 43.78 | 1238.18 ± 43.34 | 33.19 ± 3.08 | 41.11 ± 4.29 | 869.01 ± 28.78 |
AL (n = 12) | 1673.43 ± 102.05 †† | 1566.93 ± 104.13 † | 53.25 ± 5.66 †† | 33.18 ± 4.05 | 875.29 ± 10.00 |
F (n = 12) | 1015.82 ± 109.29 * &&& | 921.53 ± 110.44 ** &&& | 47.15 ± 3.66 ** | 21.33 ± 2.96 ** & | 790.13 ± 23.51 * |
F + AL (n = 12) | 1392.23 ± 55.14 & ££ | 1338.13 ± 55.19 ££ | 27.05 ± 3.66 &&& £££ | 54.05 ± 5.76 £££ | 873.17 ± 21.41 £ |
C: control group, AL: alpha-lipoic acid-treated group, F: fructose-fed group, F + AL: fructose-fed group treated with alpha-lipoic acid. † p < 0.05, †† p < 0.01: AL vs. C; * p < 0.05, ** p < 0.01: F and F + AL vs. C; & p < 0.05, &&& p < 0.001: F and F + AL vs. AL; £ p < 0.05; ££ p < 0.01, £££ p < 0.001: F + AL vs. F.